More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$4.55B
EPS
2.4
P/E ratio
132.5
Price to sales
1.86
Dividend yield
--
Beta
0.883259
Previous close
$179.27
Today's open
$179.25
Day's range
$178.74 - $183.88
52 week range
$113.37 - $192.85
show more
CEO
Vivek Jain
Employees
13000
Headquarters
San Clemente, CA
Exchange
Nasdaq Global Select
Shares outstanding
25010099
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
3 Reasons Growth Investors Will Love ICU Medical (ICUI)
ICU Medical (ICUI) could produce exceptional returns because of its solid growth attributes.
Zacks Investment Research • 14 hours ago

ICU Medical to Present at the 2026 Jefferies Global Healthcare Conference in London
SAN CLEMENTE, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 2026 Jefferies Global Healthcare Conference being held in London, November 15-18, 2026.
GlobeNewsWire • Nov 6, 2026

ICU Medical Q3 Earnings Call Highlights
ICU Medical NASDAQ: ICUI reported third-quarter revenue of $556 million and said it expects full-year adjusted earnings to finish toward the high end of its existing guidance, as growth in infusion products and improved margins offset a decline in Vital Care.
MarketBeat • Nov 6, 2026

ICU Medical, Inc. (ICUI) Q3 2026 Earnings Call Transcript
ICU Medical, Inc. (ICUI) Q3 2026 Earnings Call Transcript
Seeking Alpha • Nov 5, 2026

ICU Medical Announces Third Quarter 2026 Results and Reaffirms Fiscal Year 2026 Guidance, Expecting Results at the High End of Range
SAN CLEMENTE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2026.
GlobeNewsWire • Nov 5, 2026

ICU Medical (ICUI) Beats Q3 Earnings and Revenue Estimates
ICU Medical (ICUI) came out with quarterly earnings of $2.44 per share, beating the Zacks Consensus Estimate of $2.14 per share. This compares to earnings of $2.03 per share a year ago.
Zacks Investment Research • Nov 6, 2026

ICU Medical (ICUI) Reports Q3 Earnings: What Key Metrics Have to Say
The headline numbers for ICU Medical (ICUI) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research • Nov 6, 2026

ICU Medical Announces Time of Third Quarter 2026 Earnings Conference Call
SAN CLEMENTE, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2026 earnings release and conference call.
GlobeNewsWire • Oct 22, 2026

3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds
Here, we highlight three medical product stocks, ICUI, NEOG and TRLV, which are well positioned to benefit from industry tailwinds and could be worth adding to investors' portfolios.
Zacks Investment Research • Oct 9, 2026

ICU Medical, Inc. (ICUI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
ICU Medical, Inc. (ICUI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha • Sep 15, 2026

¹ Disclosures

Open an M1 investment account to buy and sell ICU Medical Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.